Page last updated: 2024-09-03

fosamprenavir and stavudine

fosamprenavir has been researched along with stavudine in 3 studies

Compound Research Comparison

Studies
(fosamprenavir)
Trials
(fosamprenavir)
Recent Studies (post-2010)
(fosamprenavir)
Studies
(stavudine)
Trials
(stavudine)
Recent Studies (post-2010) (stavudine)
17455371,899347357

Protein Interaction Comparison

ProteinTaxonomyfosamprenavir (IC50)stavudine (IC50)
Reverse transcriptase/RNaseH Human immunodeficiency virus 14.83

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Huff, B1
Boyle, BA1

Reviews

2 review(s) available for fosamprenavir and stavudine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
The continuing evolution of HIV therapy.
    The AIDS reader, 2003, Volume: 13, Issue:12

    Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Cyclopropanes; Delayed-Action Preparations; Deoxycytidine; Didanosine; Dideoxynucleosides; Drug Monitoring; Emtricitabine; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Oxazines; Pyridines; Randomized Controlled Trials as Topic; Stavudine; Sulfonamides; Tenofovir; Treatment Outcome; Viral Load; Zidovudine

2003

Other Studies

1 other study(ies) available for fosamprenavir and stavudine

ArticleYear
Five new drugs enter the homestretch.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 2002, Volume: 16, Issue:12

    Topics: Carbamates; Deoxycytidine; Drug Approval; Emtricitabine; Enfuvirtide; Furans; HIV Envelope Protein gp41; HIV Protease Inhibitors; Organophosphates; Peptide Fragments; Reverse Transcriptase Inhibitors; Stavudine; Sulfonamides; United States; United States Food and Drug Administration

2002